Skip to main content
Premium Trial:

Request an Annual Quote

Nanosphere Stock Offering Nets $27.7M

NEW YORK (GenomeWeb News) – Nanosphere has closed a public offering of common stock that has raised net proceeds of around $27.7 million.

The Northbrook, Ill.-based molecular diagnostics firm launched the offering last week. It sold 17,250,000 common shares at $1.75 per share, including 2,250,000 shares that made up the over-allotment option, which was exercised by the underwriters in full.

Nanosphere said that it will use the proceeds for general corporate purposes and working capital.

The company ended the second quarter with $32 million in cash and cash equivalents. In May it raised $4.7 million in net proceeds from a direct offering of its stock.

In Wednesday afternoon trade on the Nasdaq, shares of Nanosphere were down 2 percent at $1.87.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.